✦ LIBER ✦

Preclinical pharmacology, metabolic stability, pharmacokinetics and toxicology of the peptidic kinin B1 receptor antagonist R-954

✍ Scribed by Gobeil, Fernand; Sirois, Pierre; Regoli, Domenico

Book ID: 122969554
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 852 KB
Volume: 52
Category: Article
ISSN: 0196-9781
DOI: 10.1016/j.peptides.2013.12.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of ezlopitant, a novel

Pharmacokinetics of ezlopitant, a novel non-peptidic neurokinin-1 receptor antagonist in preclinical species and metabolite kinetics of the pharmacologically active metabolites

✍ Anne E. Reed-Hagen; Megumi Tsuchiya; Kaoru Shimada; Jo-Ann Wentland; R. Scott Ob 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 1 views

Pharmacological Characterization of MK-0

Pharmacological Characterization of MK-0974 [N-[(3R,6S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist for the Treatment of Migraine

✍ Salvatore, C. A.; Hershey, J. C.; Corcoran, H. A.; Fay, J. F.; Johnston, V. K.; 📂 Article 📅 2007 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 370 KB